Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou 215123, China.
Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Disease, Soochow University, Suzhou 215123, China.
Nutrients. 2018 Nov 2;10(11):1628. doi: 10.3390/nu10111628.
Metformin (Met) and lactoferrin (Lf) both exhibit beneficial effects on body weight management and lipid accumulation. However, the synergistical action of Met and Lf remains unclear. In this study, 64 mice were divided into five groups, namely, the control group, high-fat diet (HFD group), HFD with Met (Met group), Lf (Lf group), and a combination of Met and Lf (Met + Lf group). Met (200 mg/kg body weight) and Lf (2 g/100 mL) were administrated in drinking water. The experiment lasted for 12 weeks. Body weight, serum, and hepatic lipids were determined. Histology of the liver and perirenal fat was observed. Protein expression related to hepatic lipid metabolism was also measured. HFD significantly increased body weight, visceral fat weight, and lipid profiles, which lead to obesity and dyslipidemia in mice. Compared with the HFD group, the treatments significantly decreased body weight and Lee's index (body mass index of mice) with the lowest values in the Met + Lf group. The treatments also decreased the weight of visceral fat, and improved circulating lipid profile and the ability for regulating glucose intake. The adipocyte size and serum TC level were significantly lower in the Met + Lf group as compared with those in the Met or Lf group. The treatments alleviated hepatic lipid accumulation, especially in the Met + Lf group. For protein expression, the p-AMPK/AMPK ratio, a key kinase-regulating cellular energy homeostasis, was significantly higher in the Met + Lf group than the ratio in the HFD group. Similarly, the treatments significantly downregulated the protein expression of lipogenic enzymes (FAS, ACC, and SREBP-1) and upregulated the protein expression of lipolytic enzyme (ATGL). The protein expression of HMGCoAR, which is an important rate limiting enzyme in cholesterol biosynthesis, was only significantly lower in the Met + Lf group than in the HFD group. In conclusion, Met and Lf, either alone or in combination, prevented HFD-induced obesity and improved lipid metabolism.
二甲双胍(Met)和乳铁蛋白(Lf)均对体重管理和脂质堆积具有有益作用。然而,Met 和 Lf 的协同作用尚不清楚。在这项研究中,将 64 只小鼠分为五组,即对照组、高脂肪饮食组(HFD 组)、HFD 加 Met 组(Met 组)、Lf 组和 Met+Lf 联合组(Met+Lf 组)。Met(200mg/kg 体重)和 Lf(2g/100mL)通过饮用水给药。实验持续 12 周。测定体重、血清和肝脂质。观察肝和肾周脂肪的组织学变化。还测量了与肝脂质代谢相关的蛋白质表达。HFD 显著增加了体重、内脏脂肪重量和脂质谱,导致小鼠肥胖和血脂异常。与 HFD 组相比,治疗组显著降低了体重和 Lee 指数(小鼠体重指数),其中 Met+Lf 组的数值最低。治疗组还降低了内脏脂肪的重量,改善了循环脂质谱和调节葡萄糖摄入的能力。与 Met 组或 Lf 组相比,Met+Lf 组的脂肪细胞大小和血清 TC 水平显著降低。治疗组缓解了肝脂质堆积,尤其是在 Met+Lf 组。对于蛋白质表达,调节细胞能量稳态的关键激酶 p-AMPK/AMPK 比值在 Met+Lf 组中明显高于 HFD 组。同样,治疗组显著下调了生脂酶(FAS、ACC 和 SREBP-1)的蛋白表达,上调了脂解酶(ATGL)的蛋白表达。胆固醇生物合成的重要限速酶 HMGCoAR 的蛋白表达仅在 Met+Lf 组中明显低于 HFD 组。综上所述,Met 和 Lf 单独或联合使用均可预防 HFD 诱导的肥胖并改善脂质代谢。